Beyond the well-known ERBB2/HER2 or MET amplification-associated dependencies (Figure 2e and Supplementary Figure S3h), there are other gene dependencies identified in the analysis that show promising results in selected tumor types. This evidence concerns the gene ERBB2 and neoplasm.